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Cesarean scar pregnancies (CSPs) are a rare complication of previous cesarean deliveries. As cesarean
section rates continue to increase worldwide, the incidence of CSPs is likely to rise as well. The diagnosis
and management of CSPs pose challenging problems to clinicians. Early accurate diagnosis is crucial, as
CSP is a life-threatening emergency that can lead to potentially catastrophic consequences such as
uterine rupture, hemorrhage, loss of fertility and maternal death. There is no general consensus, how-
ever, regarding the best means of management. Various case reports and case series have reported
successful outcomes with medical treatment, surgical intervention, interventional radiology, as well as a
combination of methods. We present a case series of CSPs managed in our center, a tertiary obstetrics and
gynecology hospital. All were treated primarily by conservative and fertility-sparing surgical methods.
We have also included a short review of the current literature on this rare but important condition.
Copyright © 2014, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Implantation of an ectopic pregnancy within a previous cesar-
ean section scar is a rare phenomenon. The exact incidence of ce-
sarean scar pregnancies (CSPs) is reported to be 1 in 1,800e2,216,
pregnancies1,2 but is most likely increasing due to the increased
number of cesarean sections (CSs) being performed. In our center,
we deliver more than 12,000 babies a year, of which up to 30% are
delivered by cesarean section.
Current literature does not seem to show any general consensus
for the treatment of CSPs.1e11 The only conclusion based on case
reports and case series suggests that there is little or no role for a
conservative “do-nothing” approach to CSPs.4 Early diagnosis and
treatment are important to prevent the possibly catastrophic con-
sequences that may result from this rare but signiﬁcant late
complication of cesarean section. These include, but are not limited
to, uterine rupture and/or hysterectomy, with signiﬁcant morbidity
resulting from loss of fertility, disseminated intravascular coagu-
lation, and also maternal mortality.3,5s of interest.
's Hospital, 100 Bukit Timah
.
for Gynecologic Endoscopy and MinimKK Women's and Children's Hospital in Singapore is a tertiary
obstetrics and gynecology hospital that performs more than
1,500 laparoscopic operations each year. We have a dedicated
“minimally invasive surgery” department with senior staff
trained in level 3 laparoscopic and hysteroscopic procedures.
The primary aim of our study is to present our surgical experi-
ence in the management of CSPs, mainly by laparoscopy, hys-
teroscopy, suction curettage, and a combination of these
methods, in our center within a speciﬁed period. Our secondary
aim is to review the current literature available for optimal
management of CSPs.Materials and methods
We conducted a retrospective review of the CSPs diagnosed and
treated surgically in our center during the period of May 2012 to
June 2013. All cases were diagnosed on transvaginal ultrasound by a
senior radiologist and conﬁrmed intraoperatively. They were all co-
managed by the primary gynecology team and a specialist gyne-
laparoscopist in our hospital's minimally invasive surgery unit.
Conservative surgical methods e either laparoscopy or hysteros-
copy, suction curettage under ultrasound guidance, or a combina-
tion of these methods, without requiring laparotomy or
hysterectomy e were employed in the management of all our
patients.ally Invasive Therapy. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Case 2. Repeated transvaginal scan 3 days after initial presentation (as the
patient declined treatment initially) shows a gestational sac with yolk sac and fetal
pole at the site of the previous uterine scar.
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included information pertaining to age, parity, symptoms at ﬁrst
presentation, previous uterine surgery or cesarean section,
seniority of the surgeon performing previous cesarean section,
maternal serum human chorionic gonadotropin (hCG) levels, and
features of scan ﬁndings along with follow up details (Figs. 1e5).
A literature search was also performed to look at similar case
studies and case series reviews that discussed methods of man-
agement of CSPs, particularly surgical methods.
Results and case summaries
Clinical details of the patients are summarized in Table 1. Serum
hCG levels are expressed in IU/L. Cases 2 and 4, which had a more
complicated course of treatment, are described in more detail.Fig. 2. Case 2. Laparoscopic images showing excision of the cesarean scar pregnancy and the
closure of the defect. Bilateral tubes and ovaries appeared normal.Case 2
A 30-year-old Chinese woman G3P1 (1 previous 1st trimester
abortion and 1 previous Cesarean section for failure to progress 13
months earlier) presented at 5 weeks' amenorrhea having had
vaginal spotting for 1 week. She developed mild abdominal pain.
She was referred from her private obstetrician, who noted no in-
trauterine gestational sac despite ßhCG levels rising from 1,574 IU/L
to 4,357 IU/L in 48 hours. Clinical examinationwas unremarkable. A
transvaginal scan showed a 6 mm  5 mm  5 mm scar ectopic
pregnancy.
She was offered intramuscular methotrexate but the patient
initially declined treatment and wanted to seek a second opinion at
another center. She returned 3 days later. She was asymptomatic. A
transvaginal scan was repeated, which revealed a larger sac in the
same areameasuring 16mm 7mm 5mm (Fig.1). A yolk sac and
fetal pole were now visualized. No cardiac activity was noted.
Maternal serum ßhCG had risen to 31,153 IU/L. She was re-offered
systemic methotrexate and informed of the possibility of failure
of medical therapy and need for either a repeat dose of metho-
trexate or surgical intervention. The option of laparoscopic-guided
suction curettage with possible excision of the ectopic pregnancy
and uterine suturing was discussed with the patient. She was given
methotrexate initially, but eventually underwent laparoscopic-
guided suction curettage and excision of the CSP 2 days later
(Fig. 2).
Intraoperative ﬁndings were that of an 8-week sized uterus that
was very anteverted and plastered to the anterior abdominal wall
along the lower and mid segment. Both tubes and ovaries appeared
normal. There was a small amount of hemoperitoneum, estimated
to be 50 mL. There was an area of deﬁciency, 3 cm  2 cm, noted at
the anterior lower segment with products of conception (POC) seen
protruding out of the previous cesarean scar. Adhesiolysis was
performed to free up the anterior wall of the uterus. POC were then
removed from the area of perforation over the previous cesareansutured defect on the anterior uterine wall. Interrupted Vicryl-0 sutures were used for
Fig. 3. Case 3. Diagnostic laparoscopy showing the cesarean scar pregnancy. Suction curettage under direct laparoscopic guidance was performed successfully. No therapeutic
laparoscopy was required.
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2e0 and 0. Hysteroscopy conﬁrmed the presence of POC in the
endometrial cavity as well. Suction curettage was performed under
laparoscopic guidance.
The patient made an uneventful recovery, ßhCG levels dropped
to 16,993 IU/L on postoperative Day 1, and she was discharged on
postoperative Day 2. She was seen 2 weeks later and repeated
ßhCGwas 1,262 IU/L. Her ßhCG continued to fall to 194 IU/L 1 week
later. Repeat urine pregnancy test after a further 2 weeks was
negative and she had resumed menstruation in the same week.
She was extensively counseled with regards to the risk of recur-
rence of CSP, uterine rupture, and dehiscence and placenta accreta
for future pregnancies. Contraceptive advice was also given.Fig. 4. Case 4. A heterogeneous mass was seen after the resolution of the gestational sa
methotrexate injection.Case 4
A 34-year-old Indian woman G3P2 with two previous Cesarean
sections presented at 7 weeks of amenorrhea, with per vaginum
staining. She did not have any abdominal pain or giddiness. She had
taken two courses of mifepristone and misoprostol 9 days and 3
days previously, respectively. There were no prior scans carried out
prior to when she was given the prescriptions by a private doctor.
She was not on any contraception.
Transvaginal scan showed an empty uterus, with endometrial
thickness at 8.2 mm. There was a gestational sac seen at the site of
the previous uterine scar, with a fetal pole of 8.5 mm at about 7
weeks' gestation with fetal cardiac activity present. The overlyingc and fetal pole, increasing in size 2e3 weeks after initial treatment with intra-sac
Fig. 5. Case 4. Color Doppler showing increased hypervascularity of the heterogeneous
mass in the region of the scar ectopic pregnancy. The patient subsequently underwent
hysteroscopic and laparoscopic-guided suction curettage as secondary treatment.
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impression was that of a live unruptured scar ectopic pregnancy.
Serum ßhCG level was 86,116 IU/L. Hemoglobin level was 9.9 g/dL.
She remained clinically stable.
The management options were discussed with the patient.
Surgical hysteroscopic and laparoscopic removal of the sac,
evacuation, and resection of the scar ectopic pregnancy, as well as
medical management with intra-sac or intramuscular metho-
trexate were offered. She was counseled extensively about the
risks and beneﬁts of each treatment option. She decided on
ultrasound-guided intra-sac methotrexate and inpatient
monitoring.
Ultrasound-guided intra-sac methotrexate injection of 50 mg
was performed the next day. Post-procedural fetal cardiac activity
was absent. Repeat ßhCG the next day was 100,153 IU/L. She
remained hemodynamically stable and asymptomatic and she was
therefore discharged.
Repeat ßhCG 5 days post methotrexate was 101,500 IU/L. Her
hemoglobin remained stable at 9.6 g/dL. Transvaginal scan showed
a fetal pole measuring 3.1 cm  2.2 cm  2.0 cm and a cystic area
containing low-level internal echoes and some loculations. Endo-
metrial thickness was 4 mm. One week later, ßhCG further
decreased to 223,614 IU/L. Transvaginal scan was not repeated at
this visit.
Two weeks later at follow-up, the patient's ßhCG was 584 IU/L.
She was asymptomatic. Transvaginal scan showed a heterogeneous
mass with increased peripheral hypervascularity seen in the region
of the lower endometrial/endocervical canal, measuring
3.8 cm  3.5 cm  3.0 cm, with internal echoes and loculations
(Fig. 4). This was larger in size than at the previous scan. A trace
amount of free ﬂuid was seen. She was reoffered surgery in view of
the risk of rupture and hemoperitoneum due to the increase in size
of the scar ectopic. She opted for conservative management and
was given another outpatient appointment in 4 days' time.
She returned for follow up as planned, and was still asymp-
tomatic. Her repeat ßhCG measurement was 302 IU/L. Transvaginal
scan showed that the same mass had increased in size to
4.0 cm  3.7 cm  3.0 cm (Fig. 5). There was no free ﬂuid in the
pelvis. Shewas offered surgery again in view of the scar's increasing
size and higher risk of rupture. She requested tubal sterilization at
the same time.
Intraoperative ﬁndings were that of a uterus with dense adhe-
sions from the anterior wall and fundus to the anterior abdominal
wall. Both tubes and right ovary were normal but there was a small
left paraovarian cyst. Hysteroscopy showed products of conception
around the isthmus. Laparoscopic adhesiolysis was carried out.
Suction curettage was performed under direct laparoscopic guid-
ance, with a hysteroscopy check post procedure. Her bilateral tubeswere sterilized using Filschie Clips (CooperSurgical Inc., Trumbull,
CA, USA).
She was well postoperatively, and her ßhCG levels dropped to
117.9 IU/L on postoperative Day 1. She was discharged on post-
operative Day 2 and was reviewed 2 weeks post operation. She
remained clinically well. Histology conﬁrmed products of concep-
tion and a ßhCG level of 3.9 IU/L. Transvaginal scan was normal. At
further follow up 2 weeks later, her ßhCG was <1.2 IU/L and her
transvaginal scan remained normal.
Discussion
The cause and pathophysiology of CSPs is not well understood.
As described in a review article by Ash et al,4 in a cesarean scar
ectopic pregnancy, the gestation sac is completely surrounded by
myometrium and the ﬁbrous tissue of the scar, and is separate from
the endometrial cavity. The most probable mechanism is invasion
of the myometrium through a microtubular tract between the ce-
sarean section scar and the endometrial canal. Predisposing factors
therefore include previous surgery and instrumentation of the
uterus, which may cause such a microtubular tract. In our series,
three out of four women had undergone previous uterine instru-
mentation. It is uncertain whether the risk of CSP is related to the
number of previous cesarean sections. In our series, two women
had two previous CSs, whereas the other two women had one
previous cesarean section.
As we had only ﬁve cases in this series, we were unable to draw
any conclusions on the postulated predisposing factors of CSPs.
There has been little literature on this. Some review articles have
reported conﬂicting data as to whether the number of previous
lower segment CS is a strong risk factor for CSP. There are also
limited data4e6 on any correlation between the CSP and the indi-
cation of the previous CS, whether surgical technique of uterine
closure at previous CS may cause CSP, or if the time interval be-
tween the previous lower segment CS and CSP plays a contributory
role.
In our series, all ﬁve women were symptomatic with bleeding
per vaginum; three women had associated cramps. In a review of 57
cases by Rotas et al,3 38.6% of patients presented with painless
vaginal bleeding, and only 24.6% had abdominal pain. Of the 57
women, 36.8% were asymptomatic. In our series, all of the women
were diagnosed early at ﬁrst presentation, in the ﬁrst trimester. It is
important to highlight that these patients were initially seen at our
early pregnancy care unit and scanned by gynecologists, followed
by conﬁrmatory scans by trained sonographers and radiologists.
Increased awareness, high suspicion of CSPs, as well as good
sonographic skills probably contributed to early accurate diagnosis
of CSPs in our center.
Published articles to date1e9 suggest that transvaginal ultra-
sound, aided by color ﬂow Doppler, provide a high diagnostic ac-
curacy with few false positives. Diagnoses of all ﬁve women were
established by transvaginal ultrasound at presentation, early in the
ﬁrst trimester. Ultrasonic features ﬁtted the criteria as described in
the review article by Ash et al.4 These included an empty uterine
cavity, without contact with the sac; a clearly visible empty cervical
canal, without contact with the sac; the presence of the gestation
sac with or without a fetal pole with or without fetal cardiac ac-
tivity in the anterior part of the uterine isthmus; and the absence of
or a defect in the myometrial tissue between the bladder and the
sac (see Fig. 1).
Our ﬁve patients were treated with conservative surgery,
despite efforts to treat three cases with methotrexate initially. They
were all clinically stable at the point of diagnosis and treatment.
None of them required laparotomy or hysterectomy. One woman
was managed by ultrasound-guided suction curettage as the scar
Table 1
Clinical data of women with uterine scar pregnancies.
Case Age Parity Number of
weeks of
amenorrhea
Presentation Previous operation Scan features ß-hCG (IU/L) Progress and outcome Follow-up
1 30 G2P1 5 Vaginal spotting 1 CS, 1 DþC 0.8 cm  0.7 cm  0.8 cm cystic
structure with thin surrounding
echogenic rim noted at the lower
endometrial cavity which extends into
the adjacent lower segment CS scar. No
yolk sac or fetal pole.
2,011/ 5,824 (at 48 h)/
22,380 at second treatment
Failed systemic
intramuscular
methotrexate, followed by
suction curettage under
laparoscopic guidance 3 d
later.
4 wk: ßhCG 6.4;
5 wk: scan normal
2 30 G3P1 5 Vaginal spotting and
mild abdominal pain
1 CS, 1 TOP First presentation: anechoic area
0.6 cm  0.5 cm  0.5 cm with
echogenic rim at the lower segment
uterine scar. No deﬁnite yolk sac or fetal
pole.
Went to seek second opinion and
returned 3 d later. Showed
1.6 cm  0.7 cm  0.5 cm sac in the
cesarean scar area. Yolk sac and fetal
pole seen but no fetal cardiac activity.
Endometrial thickness heterogeneous
and measured 1.2 cm.
1,574/ 4,357 (at 48 h)
Went to seek second opinion.
Another 72 h later 31,153.
Systemic intramuscular
methotrexate, followed by
semi-elective laparoscopic
adhesiolysis and repair of
the scar ectopic defect at
the lower segment and
suction curettage under
laparoscopic guidance 2 d
later.
2 wk: serum ßhCG dropped
to 195.
4 wk: urine ßhCG negative.
3 25 G4P2 6 Vaginal spotting and
intermittent pain.
Unplanned pregnancy
on oral contraception
2 CS, 1 evacuation
of uterus
Sac in cesarean scar of the lower
anterior uterine wall. Yolk sac and fetal
pole seen. CRL 0.7 cm corresponding to
6 wk, 6 d of gestation, with
myometrium superﬁcial to decidual
reaction 2.3 mm in depth. Endometrial
thickness: 23 mm
34,103 Suction curettage under
laparoscopic guidance.
(Serosa intact. Did not
require therapeutic
laparoscopy.)
2 wk: post op ßhCG 150.
Defaulted follow up.
4 34 G3P2 7 Vaginal staining.
Unplanned pregnancy
and previously took 2
courses of mifepristone
and misoprostol for
TOP.
2 CS 2.7 cm  1.8 cm  1.4 cm sac seen in
lower segment of the uterus. CRL
8.5 mm corresponding to 7 wk of
gestation with fetal cardiac activity.
Overlying myometrium measured
4.2 mm.
Transvaginal ultrasound 2 wk post
methotrexate showed a heterogeneous
mass with increased peripheral
hypervascularity in the same region of
the scar ectopic pregnancy, measuring
3.8 cm  3.5 cm  3.0 cm.
Patient opted for conservative
treatment. Four d later, transvaginal
ultrasound showed increasing size of
the same mass to
4.0 cm  3.7 cm  3.0 cm. No free ﬂuid
in pelvis.
86,116
post methotrexate: Day 1
100,153/ Day 5 101,500
Day 19
584
Failed response to
ultrasound-guided intra-
gestational sac
methotrexate.
Opted for conservative
management initially.
Suction curettage under
hysteroscopic/laparoscopic
guidance about 3 wk after
methotrexate. Tubal
sterilization was also
performed at patient's
request.
6 wk: ßhCG 3.9,
transvaginal ultrasound
was normal.
8 wk: ßhCG <1.2
5 21 G3P2 5 Vaginal spotting and
right lilac fossa pain
2 CS 3.4 cm  1.2 cm  0.9 cm gestational
sac in the mid endometrial cavity,
extending towards the previous CS scar
area. The myometrium over the
gestational sac appeared thinned out.
Small yolk sac and fetal pole are seen
within the gestational sac.
35608/ 12321 (POD1)/ 330
(POD7)
Ultrasound guided suction
curettage
3 wk: hCG undetectable
CS ¼ cesarean section; CRL ¼ crown-rump length; TOP ¼ termination of pregnancy.
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maternal recovery was uneventful. None required blood
transfusion.
In a previous review from our center,10 two cases required lap-
arotomy due either to delayed presentation or delayed diagnosis.
One woman who presented late, at 16 weeks, required a subtotal
hysterectomy due to massive hemorrhage. Early recognition and
active management of CSPs seems to have eliminated the need for
laparotomy and hysterectomy during the management of these
cases in the past year. This may be explained by increased aware-
ness of the condition and the increasing use of ultrasound in early
pregnancy.
Expectant management seems to have little or no role in the
management of CSPs already diagnosed on ultrasound.4 Sadeghi
et al6 reviewed 268 cases from various case reports and series
that showed that out of 21 cases which were managed expec-
tantly, 14 women (67%) required subsequent intervention, and
six of these cases (29%) ultimately required hysterectomy. Studies
have not shown a consistent threshold of maternal serum hCG
levels or ultrasonic features that warrant a decision to choose
surgical treatment over medical treatment.4e6 Furthermore,
response to medical treatment is often unpredictable.5,6 Most
studies agree that continuation of fetal cardiac activity or growth
of the sac with rising serum hCG levels indicate failure of medical
treatment.
Blind curettage as a primary treatment for CSP is not recom-
mended by some authors.4,8 A number of authors, however, do
choose to perform suction curettage under ultrasound guidance. In
theory, the lack of direct visualization of the CSP increases the risk
of a local hematoma formation or uterine scar rupture, leading to
severe hemorrhage. In a review article of 751 CSPs, Timor-Tristsh
et al9 concluded that dilatation and curettage should be avoided
if possible as it can lead to profuse bleeding, additional secondary
backup procedures, general anesthesia, blood transfusion, and in
many instances laparotomy and loss of the uterus. It is not clear
whether this paper was speciﬁcally referring to blind dilatation and
curettage. We agree that blind dilatation and curettage should not
be used; however, our cases illustrated here all eventually under-
went suction curettage, either as a part of a primary or secondary
treatment modality. It is important to highlight that the surgeries
were all performed under laparoscopic guidance, with or without
hysteroscopic guidance.
As Ash et al4 stated in their review article, an experienced
endoscopist should make the choice between a laparoscopy and
hysteroscopy; an operative hysteroscopic approach should be
chosen for the CSP that grows inwards toward the uterine cavity,
whereas a laparoscopy is more justiﬁed for a deeply implanted
CSP growing towards the abdominal cavity and bladder. Several
reports4e6 have shown that laparoscopic excision is safe, with
limited blood loss, and is associated with fast recovery. Similarly,
hysteroscopy has a short operative time4 and direct visualization
allows for safe removal of the products of conception. A recent
case report by Chou et al7 has shown that hysteroscopic removal
of CSP can be a safe option, not only for the initial treatment but
also as rescue management after a failed methotrexate treatment
attempt. The main advantage of these surgical methods is that
fertility is conserved; however, in the event of severe hemorrhage
or hemodynamic instability, conversion to laparotomy must be
considered.
Current literature1e11 shows a wide extent of treatment mo-
dalities of CSPs, including ultrasound-guided methotrexate and
potassium chloride intra-lesional injections, systemic intramus-
cular methotrexate injections, hysteroscopic, laparoscopic and
laparotomy techniques, dilatation and curettage, uterine artery
embolization, as well as varied combinations of the abovetechniques. Uterine artery embolization as a primary treatment
should be used sparingly and only for selected cases. Transvaginal
or transabdominal ultrasound-directed methotrexate injection,
with or without additional intramuscular methotrexate, with sur-
gical excision by hysteroscopic guidance seemed to carry the lowest
complication rate. There does not, however, appear to be consensus
on choosing which mode of therapy for the management of CSP;
this is highly center-dependent and based on individual
experience.
In a retrospective case series9 of 26 patients in a single center, 19
were successfully treated with combined intramuscular and intra-
gestational methotrexate injection. Two declinedmethotrexate and
subsequently underwent hysterectomy for ruptured CSPs. In
another earlier study by Timor-Tristhsh and Monteagudo,8 the
authors suggested that systemicmethotrexate as a single treatment
of choice should be avoided, due to its slow action and as it may
require a delayed subsequent second-line treatment approach with
higher complication rate. However systemic methotrexate appears
to be more effective in women with hCG level <5,000 IU/L.2 The
success rate of systemic methotrexate treatment is 71e80%.4,6 For
levels exceeding this, intra-lesional injection and/or other addi-
tional interventions are indicated.
Follow up of the patients post treatment included clinical
assessment and monitoring of serum hCG levels for all ﬁve pa-
tients. The hCG levels were undetectable within 3e6 weeks
postoperatively. A transvaginal scan was performed for Case 1,
who was treated with intramuscular methotrexate only, and
Case 4, who initially had an increasing size of ectopic gestation
despite decreasing hCG levels after intra-sac methotrexate. This
was in line with the recommendations by Sadeghi et al.6 Our
patients all recovered uneventfully. Serum hCG levels were
measured on postoperative Day 1, and repeated 1 week later.
Subsequent hCG were repeated 1e2 weekly until levels became
undetectable, except for one patient who did not attend her
appointment.
Unfortunately due to the recent time frame of our case studies,
we were unable to look into long-term and future fertility out-
comes post-surgery for CSPs. In Sadeghi's literature review in
2010,6 follow-up data from 73 women conservatively treated for
CSPs revealed 59 subsequent pregnancies, with an overall CSP
recurrence rate of 20.5% (15 pregnancies). Of the remaining 44
pregnancies, 15 ended in elective or spontaneous abortion and
one resulted in uterine rupture causing maternal and fetal mor-
tality. In another paper by Maymon et al,11 after cesarean scar
pregnancy treatment, seven out of 18 women conceived sponta-
neously, one conceived following in vitro fertilization-
intracytoplasmic sperm injection. The remaining 10 (55%) did
not wish to conceive again. Two (25%) of the women who became
pregnant had recurrent CSP. In another series of 15 CSPs by Seow
et al,12 there were seven subsequent conceptions with two sets of
in vitro fertilization twin pregnancies. There was one recurrent
CSP, and complications reported included one hysterectomy, one
uterine rupture with maternal and fetal death, and one placenta
accreta.
Limitations
We were limited by the lack of a proper database to capture all
the scar ectopic pregnancies that have been managed in our center.
There was also a lack of a speciﬁc coding system for cesarean scar
ectopic pregnancy. Hence we could only include the cases that have
been managed over the past year. Also, due to the small numbers
and the fact that the patients were all managed by different pri-
mary surgeons, there was no standardization of treatment and
follow up protocols.
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women with previously-treated CSPs are still limited. It would be
interesting to follow up on these patients to look into the preg-
nancy outcomes of women who have had conservative surgery for
CSPs. We would also like to suggest setting up a coding system and
database to record all CSPs in our unit for further follow-up and
research purposes.
Conclusion
Currently, there is no recommended standard treatment of scar
ectopic pregnancy. We do not advocate blind dilatation and
curettage in the management of CSPs, but conclude that in expe-
rienced hands, conservative surgery is effective and safe in
hemodynamically-stable patients. Early diagnosis and treatment
likely allow success of conservative surgery, such as laparoscopic
and hysteroscopic excision and guided suction curettage. These
surgical methods appear to have good short-term outcomes and
are associated with lower maternal morbidity than laparotomy and
hysterectomy. They are also a good deﬁnitive treatment option for
patients who decline methotrexate, or patients with potentially
poor follow-up compliance.
There is little or no role for the conservative management of
CSPs. In cases presenting with greater serum hCG levels and/or
ultrasound ﬁndings of a gestational sac with fetal pole, and/or
symptoms of pain, it may be prudent to consider surgery earlier
rather than later to prevent catastrophic consequences.References
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